Moreover, the cell proliferation marker Ki67 was significantly decreased in the SMURF1 and NRF2-deficient tumor compared with the control group, and the Ki67 was significantly decreased in the NRF2-deficient tumor compared with the SMURF1-deficient tumor cells (Fig. 6L, M). The gene discussed is MKI67; the disease is neoplasm.